Search Results - "Hiemke, Christoph"

Refine Results
  1. 1

    Concentration-Effect Relationships of Psychoactive Drugs and the Problem to Calculate Therapeutic Reference Ranges by Hiemke, Christoph

    Published in Therapeutic drug monitoring (01-04-2019)
    “…Despite the obvious potential of Therapeutic Drug Monitoring (TDM) as a tool to optimize psychopharmacotherapy, especially treatment with mood-stabilizing,…”
    Get full text
    Journal Article
  2. 2

    Consensus Guideline Based Therapeutic Drug Monitoring (TDM) in Psychiatry and Neurology by Hiemke, Christoph

    Published in Current drug delivery (01-05-2016)
    “…Therapeutic drug monitoring (TDM) is a valuable tool for tailoring the dosage of the prescribed medication(s) to the individual pharmacokinetic characteristics…”
    Get more information
    Journal Article
  3. 3

    Buprenorphine–cannabis interaction in patients undergoing opioid maintenance therapy by Vierke, Christopher, Marxen, Brigitte, Boettcher, Michael, Hiemke, Christoph, Havemann-Reinecke, Ursula

    “…Buprenorphine is a partial μ-opioid agonist widely used for opioid maintenance therapy (OMT). It is mainly metabolized to pharmacologically active…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Assessing Pharmacokinetic Correlates of Escitalopram-Related Adverse Drug Reactions by Kuzin, Maxim, Haen, Ekkehard, Kuzo, Nazar, Endres, Katharina, Hiemke, Christoph, Paulzen, Michael, Schoretsanitis, Georgios

    Published in Therapeutic drug monitoring (01-04-2024)
    “…To assess the pharmacokinetic correlates of reported adverse drug reactions (ADRs) under antidepressant treatment with escitalopram (ESC) using a large…”
    Get full text
    Journal Article
  6. 6

    Potentially inappropriate medication in older psychiatric patients by Hefner, Gudrun, Hahn, Martina, Toto, Sermin, Hiemke, Christoph, Roll, Sibylle C., Wolff, Jan, Klimke, Ansgar

    Published in European journal of clinical pharmacology (01-03-2021)
    “…Purpose Many psychotropic drugs are listed as potentially inappropriate medication (PIM) in the older population. Potentially inappropriate means that…”
    Get full text
    Journal Article
  7. 7

    Astroglial Plasticity in the Hippocampus is Affected by Chronic Psychosocial Stress and Concomitant Fluoxetine Treatment by CZEH, Boldizsar, SIMON, Maria, SCHMELTING, Barthel, HIEMKE, Christoph, FUCHS, Eberhard

    Published in Neuropsychopharmacology (New York, N.Y.) (01-08-2006)
    “…Analysis of post-mortem tissue from patients with affective disorders has revealed a decreased number of glial cells in several brain areas. Here, we examined…”
    Get full text
    Journal Article
  8. 8

    Levomethadone Therapeutic Drug Monitoring to Aid Opioid Withdrawal Therapy: A Short Communication by Pfeifer, Philippe, Hildebrand, Kathrin, Angelov, Andreas, Havemann-Reinecke, Ursula, Böttcher, Michael, Hiemke, Christoph, Prentice, Tatjana, Roll, Sibylle C

    Published in Therapeutic drug monitoring (01-12-2023)
    “…Therapeutic drug monitoring (TDM) is recommended for opioid maintenance therapy with levomethadone. However, TDM has not yet been applied to monitor opioid…”
    Get full text
    Journal Article
  9. 9

    Chronic psychosocial stress and citalopram modulate the expression of the glial proteins GFAP and NDRG2 in the hippocampus by Araya-Callís, Carolina, Hiemke, Christoph, Abumaria, Nashat, Flugge, Gabriele

    Published in Psychopharmacology (01-11-2012)
    “…Rationale It has been suggested that there are causal relationships between alterations in brain glia and major depression. Objectives To investigate whether a…”
    Get full text
    Journal Article
  10. 10

    Pharmacotherapy, drug-drug interactions and potentially inappropriate medication in depressive disorders by Wolff, Jan, Reißner, Pamela, Hefner, Gudrun, Normann, Claus, Kaier, Klaus, Binder, Harald, Hiemke, Christoph, Toto, Sermin, Domschke, Katharina, Marschollek, Michael, Klimke, Ansgar

    Published in PloS one (22-07-2021)
    “…Introduction The aim of this study was to describe the number and type of drugs used to treat depressive disorders in inpatient psychiatry and to analyse the…”
    Get full text
    Journal Article
  11. 11

    Body mass index as a determinant of clozapine plasma concentrations: A pharmacokinetic-based hypothesis by Kuzin, Maxim, Haen, Ekkehard, Hiemke, Christoph, Bochon, Benjamin, Bochon, Karolina, Gründer, Gerhard, Paulzen, Michael, Schoretsanitis, Georgios

    Published in Journal of psychopharmacology (Oxford) (01-03-2021)
    “…Background: Knowledge regarding the impact of body composition measures on pharmacokinetics of antipsychotics is limited. Aims: Our aim was to investigate the…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Therapeutic Reference Ranges for Psychotropic Drugs: A Protocol for Systematic Reviews by Hart, Xenia M, Eichentopf, Luzie, Lense, Xenija, Riemer, Thomas, Wesner, Katja, Hiemke, Christoph, Gründer, Gerhard

    Published in Frontiers in psychiatry (24-11-2021)
    “…For many psychotropic drugs, monitoring of drug concentrations in the blood (Therapeutic Drug Monitoring; TDM) has been proven useful to individualize…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Body mass index (BMI) but not body weight is associated with changes in the metabolism of risperidone; a pharmacokinetics-based hypothesis by Paulzen, Michael, Haen, Ekkehard, PhD, Stegmann, Benedikt, PhD, Hiemke, Christoph, PhD, Gründer, Gerhard, Lammertz, Sarah E., PhD, Schoretsanitis, Georgios

    Published in Psychoneuroendocrinology (01-11-2016)
    “…Highlights • Body weight was shown to be a pharmacokinetic irrelevant parameter for risperidone. • BMI correlated positively with active metabolite and active…”
    Get full text
    Journal Article
  17. 17

    Pharmacokinetics of selective serotonin reuptake inhibitors by Hiemke, Christoph, Härtter, Sebastian

    “…The five selective serotonin reuptake inhibitors (SSRIs), fluoxetine, fluvoxamine, paroxetine, sertraline, and citalopram, have similar antidepressant efficacy…”
    Get full text
    Book Review Journal Article
  18. 18

    Chronic Social Stress Inhibits Cell Proliferation in the Adult Medial Prefrontal Cortex: Hemispheric Asymmetry and Reversal by Fluoxetine Treatment by Czéh, Boldizsár, Müller-Keuker, Jeanine I H, Rygula, Rafal, Abumaria, Nashat, Hiemke, Christoph, Domenici, Enrico, Fuchs, Eberhard

    Published in Neuropsychopharmacology (New York, N.Y.) (01-07-2007)
    “…Profound neuroplastic changes have been demonstrated in various limbic structures after chronic stress exposure and antidepressant treatment in animal models…”
    Get full text
    Journal Article
  19. 19

    Predicting the risk of drug–drug interactions in psychiatric hospitals: a retrospective longitudinal pharmacovigilance study by Wolff, Jan, Hefner, Gudrun, Normann, Claus, Kaier, Klaus, Binder, Harald, Domschke, Katharina, Hiemke, Christoph, Marschollek, Michael, Klimke, Ansgar

    Published in BMJ open (09-04-2021)
    “…ObjectivesThe aim was to use routine data available at a patient’s admission to the hospital to predict polypharmacy and drug–drug interactions (DDI) and to…”
    Get full text
    Journal Article
  20. 20

    Therapeutic drug monitoring for antidepressant drug treatment by Ostad Haji, Elnaz, Hiemke, Christoph, Pfuhlmann, Bruno

    Published in Current pharmaceutical design (01-12-2012)
    “…The aim of antidepressant drug treatment is to produce remission without causing adverse effects during the acute phase of the illness and to prevent relapses…”
    Get more information
    Journal Article